Related Experiment Video
Updated: Jan 14, 2026

08:53
Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
1.5K
The Effects of Transcranial Direct Current Stimulation on Acute Ischemic Stroke-A Randomized, Double-blind,
Seong-Hoon Kim1, Taewon Kim2, Jaseong Koo3
1Department of Neurology, Uijeongbu St. Mary's Hospital.
The Neurologist
|October 24, 2025
Summary
This study found that transcranial direct current stimulation (tDCS) is safe for acute ischemic stroke patients. While it did not significantly improve motor or neurological outcomes, there was a trend towards reduced early neurological deterioration.
Area of Science:
- Neurology
- Neurosurgery
- Rehabilitation Medicine
Background:
- Transcranial direct current stimulation (tDCS) is a noninvasive neuromodulation technique with potential benefits for motor and cognitive recovery in chronic stroke.
- Its application in the acute phase of ischemic stroke is not well-established.
Purpose of the Study:
- To investigate the safety and efficacy of tDCS in acute ischemic stroke patients.
- To assess the impact of tDCS on motor function, neurological status, and functional outcomes.
Main Methods:
- A randomized, double-blind, sham-controlled trial involving 60 acute ischemic stroke patients within 2 days of onset.
- Participants received 5 sessions of either real tDCS or sham stimulation over 7 days.
- Primary outcomes included changes in Fugl-Meyer (FM) motor scale, NIHSS scores, early neurological deterioration, and modified Rankin Scale (mRS) at 3 months.
Main Results:
- Early neurological deterioration occurred in 6.7% of the tDCS group versus 26.7% in the sham group (P=0.065).
- No statistically significant differences were found between groups for FM scores, NIHSS scores, or favorable functional outcomes (mRS ≤2) at 3 months.
- No significant group-by-time interactions were observed for FM or NIHSS scores.
Conclusions:
- Transcranial direct current stimulation (tDCS) is safe for acute ischemic stroke patients.
- While tDCS did not demonstrate significant improvements in motor or neurological outcomes compared to sham, a trend towards reduced early neurological deterioration was observed.
- Further research is warranted to explore the potential of tDCS in mitigating early neurological decline in acute stroke.

